Use of ticagrelor alongside fibrinolytic therapy in patients with ST‐segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study

作者：OtavioBerwanger; MagdyAbdelhamid; ThomasAlexander; AbdulmajeedAlzubaidi; OlegAverkov; PhilipAylward; EduardoContrerasZúiga; SigrunHalvorsen; RicardoIglesias; MuhamadA SK AbdulKader; MohammadZubaid; KhalidF AlHabib

来源：Clinical Cardiology, 2018, 41(10): 1322-1327.

DOI：10.1002/clc.23043

• Fibrinolysis
• Reperfusion therapy
• ST‐segment elevation myocardial infarction
• Ticagrelor
• TREAT study

Primary percutaneous coronary intervention (PCI) is the preferred reperfusion method in patients with ST‐segment elevation myocardial infarction (STEMI). In patients with STEMI who cannot undergo timely primary PCI, pharmacoinvasive treatment is recommended, comprising immediate fibrinolytic therapy...